Search results

This guideline covers identifying and managing familial hypercholesterolaemia (FH), a specific type of high cholesterol that runs in the family, in children, young people and adults. It aims to help identify people at increased risk of coronary heart disease as a result of having FH.

Result type

Clinical guideline

Last updated

4 October 2019

NICE has developed a medtech innovation briefing (MIB) on Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions .

Result type

Medtech innovation briefing

Published

29 November 2016

Evidence-based recommendations on totally endoscopic robotically assisted coronary artery bypass grafting (TECAB). This involves using small, remote-controlled robotic arms to carry out the grafting procedure.

Result type

Interventional procedures guidance

Published

22 June 2005

Summary of the evidence on avanafil for treating erectile dysfunction to inform local NHS planning and decision-making

Result type

Evidence summary

Published

12 August 2014

This guideline covers how to identify the adults, young people and children with non-alcoholic fatty liver disease (NAFLD) who have advanced liver fibrosis and are most at risk of further complications. It outlines the lifestyle changes and pharmacological treatments that can manage NAFLD and advanced liver fibrosis.

Result type

NICE guideline

Published

6 July 2016

NICE has developed a medtech innovation briefing (MIB) on Optowire for measuring fractional flow reserve .

Result type

Medtech innovation briefing

Published

3 December 2019

Evidence-based recommendations on percutaneous laser coronary angioplasty. This involves using a laser to burn away the deposits blocking the blood vessels of the heart.

Result type

Interventional procedures guidance

Published

26 January 2011

Summary of the evidence on omega-3 fatty acid medicines for treating schizophrenia to inform local NHS planning and decision-making

Result type

Evidence summary

Published

24 September 2013

Early value assessment (EVA) on digital platforms to support cardiac rehabilitation....

Result type

Health technology evaluation

Published

4 December 2025

This guideline covers identifying and treating primary hypertension (high blood pressure) in people aged 18 and over, including people with type 2 diabetes. It aims to reduce the risk of cardiovascular problems such as heart attacks and strokes by helping healthcare professionals to diagnose hypertension accurately and treat it effectively.

Result type

NICE guideline

Last updated

21 November 2023

Evidence-based recommendations on edoxaban (Lixiana) for preventing stroke and systemic embolism in adults with non-valvular atrial fibrillation.

Result type

Technology appraisal guidance

Last updated

2 July 2021

Evidence-based recommendations on implanting a baroreceptor stimulation device for resistant hypertension. This involves using electrical impulses from the device that stimulate baroreceptors to help the body lower blood pressure.

Result type

Interventional procedures guidance

Published

28 October 2015

Evidence-based recommendations on alirocumab (Praluent) for treating primary hypercholesterolaemia or mixed dyslipidaemia in adults.

Result type

Technology appraisal guidance

Published

22 June 2016

Evidence-based recommendations on percutaneous laser revascularisation for refractory angina pectoris. This involves inserting a catheter into major vessels of the groin, which is advanced to the heart, to drill holes on the heart muscle using a laser beam.

Result type

Interventional procedures guidance

Published

27 May 2009

Evidence-based recommendations on short-term circulatory support with left ventricular assist devices (LVAD) as a bridge to heart transplantation or recovery. This involves inserting a mechanical device into the chest to help the heart pump blood around the body.

Result type

Interventional procedures guidance

Published

28 June 2006